Publications by authors named "Victor M Hidalgo-Olivares"
Background: The optimal radiofrequency application (RFa) parameters for safe and durable pulmonary vein isolation (PVI) are debated. High-power short-duration (HPSD) has been used as an alternative to conventional power delivery (CPD).
Objectives: This study sought to compare HPSD 70 W/9-10 s (HPSD-70) with CPD 25-40 W in patients undergoing PVI.
Introduction And Objectives: We report the results of the 2023 Spanish catheter ablation registry.
Methods: Procedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form.
Results: There were 104 participating centers in 2023 compared with 103 in 2022.
Multicenter prospective comparison of conventional and high-power short duration radiofrequency application for pulmonary vein isolation: the high-power short-duration radiofrequency application for faster and safer pulmonary vein ablation (POWER FAST III) trial.
J Interv Card Electrophysiol
November 2023
Article Synopsis
- A multicenter clinical trial called POWER FAST III is set to compare high-power short-duration (HPSD) radiofrequency ablation with standard techniques for treating atrial fibrillation (AF), aiming to reduce procedure time without sacrificing safety or effectiveness.
- The study involves two groups: one using higher power settings (70 W and 9-10 seconds) and another using lower power (25-40 W), measuring atrial arrhythmia recurrence and the risk of esophageal damage.
- Results are expected to potentially validate the HPSD approach, influencing future clinical practices for AF ablation procedures.
Background: Filamin C (encoded by the FLNC gene) is essential for sarcomere attachment to the plasmatic membrane. FLNC mutations have been associated with myofibrillar myopathies, and cardiac involvement has been reported in some carriers. Accordingly, since 2012, the authors have included FLNC in the genetic screening of patients with inherited cardiomyopathies and sudden death.
View Article and Find Full Text PDFObjective: To compare the prognosis during hospitalization and maximum follow-up of 4 years in patients with myocardial infarction complicated with cardiogenic shock.
Method: Prospective observational study practiced in a coronary Care Unit managed by cardiologists. We included patients with myocardial infarction complicated with cardiogenic shock who received early coronary revascularization.